columbia financial inc - CLBK
CLBK
Close Chg Chg %
17.58 0.08 0.46%
Closed Market
17.66
+0.08 (0.46%)
Volume: 182.18K
Last Updated:
Apr 2, 2026, 4:00 PM EDT
Company Overview: columbia financial inc - CLBK
CLBK Key Data
| Open $17.40 | Day Range 17.38 - 17.70 |
| 52 Week Range 12.64 - 18.87 | Market Cap $1.84B |
| Shares Outstanding 104.12M | Public Float 26.41M |
| Beta 0.19 | Rev. Per Employee N/A |
| P/E Ratio 34.74 | EPS $0.51 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 273.67K |
CLBK Performance
| 1 Week | 2.50% | ||
| 1 Month | -2.21% | ||
| 3 Months | 14.53% | ||
| 1 Year | 31.59% | ||
| 5 Years | 0.40% |
CLBK Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
2
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | HOLD | Average Target Price | 18.00 | |
| Number of Ratings | 2 | Current Quarters Estimate | 0.165 | |
| FY Report Date | 06 / 2026 | Current Year's Estimate | 0.755 | |
| Last Quarter’s Earnings | 0.155 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 0.543 | Next Fiscal Year Estimate | 0.79 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 2 | 2 | 2 | 2 |
| Mean Estimate | 0.17 | 0.21 | 0.76 | 0.79 |
| High Estimates | 0.17 | 0.21 | 0.77 | 0.79 |
| Low Estimate | 0.16 | 0.20 | 0.74 | 0.79 |
| Coefficient of Variance | 4.29 | 3.45 | 2.81 | 0.00 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 0 | 0 | 0 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 2 | 2 | 1 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Hold | Hold | Hold |
SEC Filings for Columbia Financial Inc - CLBK
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Columbia Financial Inc - CLBK
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Mar 17, 2026 | Paul van Ostenbridge Director | 2,952 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $17.43 per share | 51,453.36 |
| Mar 17, 2026 | Robert van Dyk Director | 2,952 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $17.43 per share | 51,453.36 |
| Mar 17, 2026 | Noel R. Holland Director | 2,952 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $17.43 per share | 51,453.36 |
| Mar 17, 2026 | Michael Massood Director | 2,952 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $17.43 per share | 51,453.36 |
| Mar 17, 2026 | Elizabeth E. Randall Director | 2,952 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $17.43 per share | 51,453.36 |
| Mar 17, 2026 | James M. Kuiken Director | 2,952 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $17.43 per share | 51,453.36 |
| Mar 17, 2026 | Lucy Sorrentini Director | 2,952 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $17.43 per share | 51,453.36 |
| Mar 17, 2026 | Daria Stacy-Walls Torres Director | 2,952 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $17.43 per share | 51,453.36 |
| Jan 14, 2026 | Thomas J. Kemly President & CEO; Director | 66,606 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $15.3 per share | 1,019,071.80 |
| Jan 14, 2026 | John Klimowich SEVP & Chief Risk Officer | 8,183 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $15.3 per share | 125,199.90 |
| Dec 3, 2025 | Allyson Schlesinger SEVP&Head of Consumer Banking | 13,503 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $15.83 per share | 213,752.49 |
| Nov 6, 2025 | Manesh Balachandran Prabhu EVP & CIO | 4,857 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $14.75 per share | 71,640.75 |
| Oct 15, 2025 | W. Justin Jennings EVP, Operations Officer | N/A | Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 | 0.00 |
| Oct 15, 2025 | W. Justin Jennings EVP, Operations Officer | N/A | Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 | 0.00 |
| Sep 24, 2025 | Jenifer Walden EVP & CHRO | 2,810 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $15.51 per share | 43,583.10 |